Welcome to Business of Athletes, your weekly briefing on the business being built around athletes. Here’s what matters this week, from the stories worth following to the deals getting done.
Headliner
Beckham’s IM8 signs NBA sponsorship deal
Driving the news: David Beckham’s supplement brand IM8 became the NBA’s official nutrition partner in Australia and eight Southeast Asian markets on Oct. 12 (NBA).
By the numbers:
9 markets covered by the sponsorship, including Australia, Indonesia, Malaysia, Singapore and the Philippines.
$251 million in annualized revenue run rate for IM8, based on its July sales, according to parent company Prenetics.
$220 million–$230 million in projected full-year 2026 IM8 revenue, according to Prenetics’ August guidance.
Between the lines: Beckham joined IM8 as a co-founder and equity partner rather than a paid ambassador. Yeung told Fox Business that Beckham backed Prenetics when its market capitalization was about $40 million and remained involved as the company grew.
Zoom in: Beckham is one of several athletes with equity ties to IM8. Giannis Antetokounmpo joined in April under an endorsement agreement that pays him entirely in shares rather than cash.
Reality check: IM8 is wholly owned by publicly traded Prenetics. The sponsorship’s financial terms and Beckham’s individual ownership percentage have not been disclosed.



